Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma

被引：0
|
作者：
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Musuraca, Gerardo
Lucchesi, Alessandro
Pane, Fabrizio
Martinelli, Giovanni
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-143189
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pomalidomide in lenalidomide-refractory multiple myeloma: Far from futile
    Mo, Clifton C.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 483 - 485
  • [42] Addition of carfilzomib as a third agent in lenalidomide-refractory multiple myeloma: Switching from doublet to triplet.
    Cerchione, Claudio
    Nappi, Davide
    Catalano, Lucio
    Ronconi, Sonia
    Cangini, Delia
    Ceccolini, Michela
    Musuraca, Gerardo
    Martinelli, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma (vol 6,e786, 2022)
    不详
    HEMASPHERE, 2023, 7 (03):
  • [44] A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse
    Bhutani, Manisha
    Foureau, David M.
    Robinson, Myra
    Guo, Fei
    Fesenkova, Kateryna
    Atrash, Shebli
    Paul, Barry
    Varga, Cindy
    Friend, Reed
    Pineda-Roman, Mauricio
    Rigby, Katherine
    Symanowski, James T.
    Norek, Sarah
    Tucker, Mallory R.
    Druhan, Lawrence J.
    Voorhees, Peter M.
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07): : 535 - +
  • [45] INTERIM ANALYSIS OF CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE VS CARFILZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE IN THE FORTE TRIAL
    Gay, F.
    Spadano, A.
    Cavo, M.
    Caravita, T.
    Canepa, L.
    Giuliani, N.
    Spada, S.
    Patriarca, F.
    Morabito, F.
    Tacchetti, P.
    Narni, F.
    De Sabbata, G.
    De Santis, F.
    Pascarella, A.
    Palmieri, S.
    Liberati, A. M.
    Pisani, F.
    Genuardi, M.
    Tosi, P.
    Annibali, O.
    Ruggeri, M.
    Curci, P.
    De Rosa, L.
    Palumbo, A.
    Musto, P.
    Boccadoro, M.
    HAEMATOLOGICA, 2017, 102 : 1 - 1
  • [46] Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
    Vesole, David H.
    Bilotti, Elizabeth
    Richter, Joshua R.
    McNeill, Ann
    McBride, Laura
    Raucci, Laura
    Anand, Palka
    Bednarz, Urszula
    Ivanovski, Kristin
    Smith, Judith
    Batra, Veena
    Aleman, Adolfo
    Sims, Taliah
    Guerrero, Laura
    Mato, Anthony
    Siegel, David S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (01) : 52 - 59
  • [47] Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience
    Zherebtsova, Vera A.
    Vorobyev, Vladimir, I
    Gemdzhian, Eduard G.
    Ulyanova, Margarita A.
    Chernikov, Mikhail, V
    Ivanova, Valentina L.
    Vinogradova, Olga Yu
    Ptushkin, Vadim V.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (07) : 785 - 792
  • [48] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE VS CARFILZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE INDUCTION: PLANNED INTERIM ANALYSIS OF THE RANDOMIZED FORTE TRIAL IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Gay, F.
    Scalabrini, D. Rota
    Belotti, A.
    Offidani, M.
    Tacchetti, P.
    Petrucci, M. T.
    Pautasso, C.
    Palmas, A. D.
    Siniscalchi, A.
    Grasso, M.
    Spadano, A.
    Giuliani, N.
    Ballanti, S.
    Patriarca, F.
    Canepa, L.
    Bernardini, A.
    Aquino, S.
    Gamberi, B.
    Zambello, R.
    Ledda, A.
    Montefusco, V.
    Omede, P.
    Galli, M.
    Cavo, M.
    Palumbo, A.
    Musto, P.
    Boccadoro, M.
    HAEMATOLOGICA, 2017, 102 : 143 - 144
  • [49] Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma
    Richter, Joshua R.
    Bilotti, Elizabeth
    McBride, Laura
    Schmidt, Linda
    Gao, Zhijie
    Tufail, Madiha
    Anand, Palka
    McNeill, Ann
    Bednarz, Urszula
    Graef, Thorsten
    Vesole, David H.
    Siegel, David S.
    BLOOD, 2011, 118 (21) : 1706 - 1706
  • [50] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
12345